Head and Neck Cancer — Erlotinib and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Citation(s)
A Phase I/II Study Of OSI-774 In Combination With Cisplatin In Patients With Recurrent Or Metastatic Squamous Cell Cancer Of The Head And Neck